Cargando…
Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706174/ https://www.ncbi.nlm.nih.gov/pubmed/25381819 http://dx.doi.org/10.1038/onc.2014.361 |
_version_ | 1782409128798322688 |
---|---|
author | Sriram, Ganapathy Jankowski, Wojciech Kasikara, Canan Reichman, Charles Saleh, Tamjeed Nguyen, Khanh-Quynh Li, Jing Hornbeck, Peter Machida, Kazuya Liu, Tong Li, Hong Kalodimos, Charalampos G. Birge, Raymond B. |
author_facet | Sriram, Ganapathy Jankowski, Wojciech Kasikara, Canan Reichman, Charles Saleh, Tamjeed Nguyen, Khanh-Quynh Li, Jing Hornbeck, Peter Machida, Kazuya Liu, Tong Li, Hong Kalodimos, Charalampos G. Birge, Raymond B. |
author_sort | Sriram, Ganapathy |
collection | PubMed |
description | Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we show using LC-MS/MS and by generating phosphospecific antibodies that, iteratively with Y221, the Crk SH3C is routinely phosphorylated on Y239 and/or Y251 by several extracellular stimuli known to engage Crk. While phosphorylation at Y221 auto-inhibits the Crk SH2, phosphorylation of the SH3C generates an unconventional phosphoSH3C-SH3N unit in which the SH3N is fully functional to bind Polyproline Type II (PPII) ligands and the phosphoSH3C binds de novo to other SH2 domains. Using high throughput SH2 domain profiling, artificial neural network and position-specific scoring matrix based bio-informatics approaches, and unbiased MS, we found that the phosphoSH3C binds several SH2 domain-containing proteins, including specific non-receptor tyrosine kinases - Abl via pY251 and Csk via pY239. Functionally, we show that the phosphoSH3C modulates the Abl-mediated phenotypes of cell spreading and motility. Together, these studies describe a versatile mechanism wherein phosphorylation of Crk at Y221 is not an off switch but redirects signaling from the SH2-SH3N axis to a phosphoSH3C-SH3N axis, with the SH3N as a common denominator. |
format | Online Article Text |
id | pubmed-4706174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-47061742016-02-06 Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk Sriram, Ganapathy Jankowski, Wojciech Kasikara, Canan Reichman, Charles Saleh, Tamjeed Nguyen, Khanh-Quynh Li, Jing Hornbeck, Peter Machida, Kazuya Liu, Tong Li, Hong Kalodimos, Charalampos G. Birge, Raymond B. Oncogene Article Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we show using LC-MS/MS and by generating phosphospecific antibodies that, iteratively with Y221, the Crk SH3C is routinely phosphorylated on Y239 and/or Y251 by several extracellular stimuli known to engage Crk. While phosphorylation at Y221 auto-inhibits the Crk SH2, phosphorylation of the SH3C generates an unconventional phosphoSH3C-SH3N unit in which the SH3N is fully functional to bind Polyproline Type II (PPII) ligands and the phosphoSH3C binds de novo to other SH2 domains. Using high throughput SH2 domain profiling, artificial neural network and position-specific scoring matrix based bio-informatics approaches, and unbiased MS, we found that the phosphoSH3C binds several SH2 domain-containing proteins, including specific non-receptor tyrosine kinases - Abl via pY251 and Csk via pY239. Functionally, we show that the phosphoSH3C modulates the Abl-mediated phenotypes of cell spreading and motility. Together, these studies describe a versatile mechanism wherein phosphorylation of Crk at Y221 is not an off switch but redirects signaling from the SH2-SH3N axis to a phosphoSH3C-SH3N axis, with the SH3N as a common denominator. 2014-11-10 2015-08-06 /pmc/articles/PMC4706174/ /pubmed/25381819 http://dx.doi.org/10.1038/onc.2014.361 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Sriram, Ganapathy Jankowski, Wojciech Kasikara, Canan Reichman, Charles Saleh, Tamjeed Nguyen, Khanh-Quynh Li, Jing Hornbeck, Peter Machida, Kazuya Liu, Tong Li, Hong Kalodimos, Charalampos G. Birge, Raymond B. Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title | Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title_full | Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title_fullStr | Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title_full_unstemmed | Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title_short | Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk |
title_sort | iterative tyrosine phosphorylation controls non-canonical domain utilization in crk |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706174/ https://www.ncbi.nlm.nih.gov/pubmed/25381819 http://dx.doi.org/10.1038/onc.2014.361 |
work_keys_str_mv | AT sriramganapathy iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT jankowskiwojciech iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT kasikaracanan iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT reichmancharles iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT salehtamjeed iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT nguyenkhanhquynh iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT lijing iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT hornbeckpeter iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT machidakazuya iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT liutong iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT lihong iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT kalodimoscharalamposg iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk AT birgeraymondb iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk |